Report: FDA’s Mifepristone Safety Review Could Be Completed by September

The news comes after the agency earlier this month confirmed that its review was moving into a new data analysis phase.

FDA Confirms It’s Moving Forward with New Phase of Mifepristone Safety Review

‘Every woman deserves the highest standard of medical care,’ said Carol Tobias, president of National Right to Life. ‘We encourage the agency to conduct this review with transparency, scientific integrity, and an unwavering commitment to protecting women.’

Tagged abortionabortion drugsadverse eventschemical abortioncoercionEPPCEPPC studyEthics and Public Policy CenterFDAFood and Drug Administrationforced abortionmifepristone reviewsafetysafety reviewUS Food and Drug Administrationwomen